Piomic Medical raises USD 25 M

An ETH Zurich start-up, Piomic Medical is developing COMS One, a portable, non-invasive device for treating chronic wounds. It has closed a USD 25 million growth round led by Swisscanto, to complete its clinical trials and prepare approval and launch in the United States.

Announced on
Round
Growth
Amount
USD 25 M
Location
canton of Zurich
Sector
Health & medtech

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic